Notitia

Wilmington, United States Founded: 2019 • Age: 7 yrs
Therapeutic solutions for diabetes and infectious diseases are developed.

About Notitia

Notitia is a Healthcare company based in Wilmington (United States) founded in 2019 by Liping Zhao and Jeffrey Zhao. Therapeutic solutions for diabetes and infectious diseases are developed. Notitia has raised $1.5 million across 2 funding rounds. Its chief executive, as recorded, is Jeffrey Zhao. Its focus areas include Life Sciences, Diabetes and Drugs. Its legal entity is Notitia Biotechnologies Co. Its competitors include Sana Biotechnology, Semma Therapeutics and Rezolute; 2 of its 3 listed competitors have raised funding.

Company details

Notitia was founded in 2019 and is headquartered in Wilmington, United States. Operations focus on biotechnology, with therapeutic solutions developed for diabetes and infectious diseases. Key products include NBT-NM108, a high-fiber nutrient-mix drink targeted at COVID-19 and respiratory viral infections in type 2 diabetes patients, and NBT-LP306 for early-stage diabetic kidney disease. Additional solutions address Prader-Willi Syndrome.

  • Headquarters Wilmington, United States
  • Founders Liping Zhao, Jeffrey Zhao
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website notitiabio.com
  • Social LinkedIn
  • Legal Name Notitia Biotechnologies Co
Operational Areas
Key Metrics
  • Total Equity Funding
    $1.5M (USD)

    in 2 rounds

Funding Insights of Notitia

Notitia has successfully raised a total of $1.5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.5M
  • Total Rounds 2
  • First Round $1.5M

    (Nov 2020)

All 2 funding rounds of Notitia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2020$1.5MSeed––
–
Nov 2020Debt – Conventional––
–

People of Notitia

6 people are tracked at Notitia (2 in leadership, 4 in board & advisors).

NameRoleGroup
Liping Zhao
Co-FounderLeadership
Jeffrey Zhao
Co-Founder & CEOLeadership
Gregory Stokes
Business Development AdvisorBoard & advisors
Margaret McFall-Ngai
Scientific AdvisorBoard & advisors
George Weinstock
Scientific AdvisorBoard & advisors
Jeff Miller
Scientific AdvisorBoard & advisors
Premium access

Complete people profiles for Notitia

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Notitia

2 dated milestones of Notitia across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Notitia is founded.
  2. Funding First funding round of $1.5M.

Competitors of Notitia

Notitia has 3 listed competitors in our database, 2 of them funded. They include Sana Biotechnology, Semma Therapeutics and Rezolute.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sana.com2018Seattle, United States$821M328
Genetically engineered cell therapies are developed for multiple disorders.
semma-tx.com2015Cambridge, United States$158M58
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
rezolutebio.com2012Denver, United States51
Therapies for metabolic and orphan diseases are developed by Rezolute.
Premium access

Detailed competitors of Notitia

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Notitia

Websites that share an audience with Notitia (notitiabio.com).

Similar websites

Websites whose visitors overlap most with Notitia. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sonnetbio.com
100%
10K#2,355,636View details
otradi.org
97%
#8,709,976View details
synbio-tech.com
77%
21.9K#1,181,176View details

Top companies in Diabetes

3 companies that operate in the same segment as Notitia (Diabetes) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of devices for continuous glucose monitoring and manual insulin delivery
2008San Diego, California, United StatesUSD 100.73 MUSD 1.02 B2,650
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Notitia

Notitia was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Notitia is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

Jeffrey Zhao is the CEO of Notitia, as recorded in our data. They have also founded this company.

Notitia is a funded company, having raised a total of $1.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Nov 2020.

Notitia was founded in 2019 and is headquartered in Wilmington, United States. Operations focus on biotechnology, with therapeutic solutions developed for diabetes and infectious diseases. Key products include NBT-NM108, a high-fiber nutrient-mix drink targeted at COVID-19 and respiratory viral infections in type 2 diabetes patients, and NBT-LP306 for early-stage diabetic kidney disease. Additional solutions address Prader-Willi Syndrome.

Notitia's top competitors include Sana Biotechnology, Semma Therapeutics and Rezolute.

Notitia operates through Notitia Biotechnologies Co.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available